- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® Research Roundup: August 2019
Here are 5 interesting findings from the August 2019 issue of AJMC®.
Hi, I’m Christina Mattina for The American Journal of Managed Care®. Here are 5 findings from research published in the August issue.
The Potential Impact of CAR T-Cell Treatment Delays on Society
1. Treatment with CAR T-cell therapy provides significant benefit to patients with 2 types of cancers and results in billions of dollars gained in social value. But without access to treatment, patients lose large chunks of that value, leading the study authors to suggest that barriers to this therapy should be minimized.
2. California’s new policy setting out-of-network payment standards for nonemergency physician services has shifted leverage in negotiations in favor of payers, who now have an incentive to cancel contracts with rates higher than the standard, according to interviews with a wide range of stakeholders.
Passive Social Health Surveillance and Inpatient Readmissions
3. Data from a social health surveillance system indicate that individuals who reported social needs (such as food insecurity or transportation needs) were more likely to have an inpatient readmission within 30, 90, and 180 days than individuals without such needs.
Access to Chiropractic Care and the Cost of Spine Conditions Among Older Adults
4. When Medicare beneficiaries moved to an area with higher accessibility of chiropractic care, there were associated decreases in spending on spine evaluation and management as well as diagnostic imaging and testing, suggesting the potential for significant savings considering the large volume of older Americans with spine conditions.
5. Prompt detection and treatment of hepatitis C virus is key to achieving improved outcomes, but many infections are not diagnosed until cirrhosis or end-stage liver disease occurs, representing missed opportunities to intervene earlier in the disease process, according to a large cohort study.
To read all of these studies and more, visit AJMC.com.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Early Involvement Critical in Treating Immunotherapy-Induced Overlap Syndrome
April 19th 2024A series of case studies reveals the importance of early diagnosis and involvement of special teams of clinicians when dealing with potential cases of overlap syndrome, which encompasses myocarditis, myasthenia gravis, and immune checkpoint inhibitor–related myositis.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
